Each of those is a genuinely different clinical situation, and each points to a different conclusion about whether switching to a tablet is worth pursuing
Skin is a vital part of our body, so if you face any persistent issues ranging from acne, discolouration, severe pigmentation, or premature ageing, it may be due to serious health issues
Even if the box looks real, there is no guarantee that what is inside is safe or suitable for you
Safety & Key Considerations Common GI adverse effects (class-related) Important risks: pancreatitis, AKI, gallbladder disease, hypoglycemia Boxed warning: thyroid C-cell tumors Contraindicated in MTC and MEN2 Clinical Takeaways Do not combine with other GLP-1 receptor agonists Represents a major shift toward non-injectable incretin therapy Likely to compete with agents like Semaglutide and Tirzepatide May significantly expand real-world uptake, especially in patients hesitant about injections Big Picture This isnt just a new drug it signals a paradigm shift
Hegde S, Akbar H, Zheng Y, Cancelas JA
